Australian Clinical Labs Limited

ASX ACL.AX

Australian Clinical Labs Limited EBITDA Margin for the year ending June 30, 2024: 24.60%

Australian Clinical Labs Limited EBITDA Margin is 24.60% for the year ending June 30, 2024, a -7.95% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Australian Clinical Labs Limited EBITDA Margin for the year ending June 30, 2023 was 26.72%, a -29.08% change year over year.
  • Australian Clinical Labs Limited EBITDA Margin for the year ending June 30, 2022 was 37.68%, a 22.86% change year over year.
  • Australian Clinical Labs Limited EBITDA Margin for the year ending June 30, 2021 was 30.67%, a 28.56% change year over year.
  • Australian Clinical Labs Limited EBITDA Margin for the year ending June 30, 2020 was 23.85%, a 2,607.91% change year over year.
Key data
Date EBITDA Margin EBIT Margin Depreciation and Amortization EBIT
Market news
SV Wall Street
ASX: ACL.AX

Australian Clinical Labs Limited

CEO Ms. Melinda McGrath
IPO Date May 14, 2021
Location Australia
Headquarters 1868-1892 Dandenong Road
Employees 4,900
Sector Healthcare
Industries
Biotechnology Cleaning Supplies Clinical Trials Dental Care Insurance Medical Instruments Personal Care Telehealth
Description

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. The company was incorporated in 2020 and is headquartered in Clayton, Australia.

Similar companies

HLS.AX

Healius Limited

USD 0.85

-1.43%

StockViz Staff

February 7, 2025

Any question? Send us an email